Latest Financials News

Patronus Resources reports a robust $70 million in cash and investments alongside 2.3 million ounces of gold equivalent resources, underpinning a multi-commodity growth strategy across Western Australia and the Northern Territory.

WhiteHawk Limited has announced the listing of nearly 93.5 million free-attaching options issued under its August 2025 placement, exercisable at $0.02 and expiring in 2028. These options, approved by shareholders, could raise close to $1.87 million if fully exercised.

Aurora Energy Metals reports a breakthrough in uranium processing at its Oregon project, achieving high recoveries with significantly reduced acid consumption and simplified operations.

Pacific Edge reports a 9% decline in Cxbladder test volumes amid Medicare coverage loss but gains momentum with new clinical validation and a CMS pricing boost.

Meridian Energy’s September 2025 report reveals exceptional hydro storage levels and a notable uptick in electricity demand and retail sales, setting a positive tone for the company’s near-term outlook.

Garda Property Group has announced its distribution components for the year ending June 2026, highlighting key tax elements and a total cash payout scheduled for mid-October.

Amplitude Energy has successfully closed a $150 million equity raising, including a $19 million retail entitlement offer, positioning the company to expand its East Coast Supply Project and potentially restart the Patricia Baleen project.

Tungsten Mining NL is moving to list on the U.S. OTCQB Market, aiming to tap into strong North American investor interest as tungsten prices climb and critical mineral security becomes a priority.

Magnum Mining and Exploration Limited has had its trading suspension lifted following a key announcement on capital raising, reopening the stock to market activity.

ECP Emerging Growth Limited has reported a stable financial position for its convertible notes in Q3 2025, with a loan-to-value ratio of just 21.54% and no changes to the conversion price.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.